Karthikeyan Radhakrishnan

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Replacement Therapy

Extracellular Matrix

End Stage Renal Disease

Top Venues

EMBO molecular medicine

Molecular genetics & genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregula, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregula, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Orna Staretz-Chacham, Lars Schlotawa, Ohad Wormser, Inbal Golan-Tripto, Ohad S Birk, Carlos R Ferreira, Thomas Dierks, Karthikeyan Radhakrishnan
A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency. Molecular genetics & genomic medicine 8 (9) (2020)